Scholarships awarded to more than two dozen researchers

Researchers and scientists from across the globe will travel to San Antonio for the 42nd annual San Antonio Breast Cancer Symposium® (SABCS®) Dec. 10-14. More than two dozen will be attending with scholarships awarded through SABCS and its co-sponsor, the American Association of Cancer Research (AACR).

The scholarships were awarded to poster and spotlight session presenters. Included are those receiving the first ever memorial scholarships for SABCS co-founder Charles Coltman and Arti Hurria. Hurria, who was scheduled to present in 2018 was killed in an auto collision. Coltman, co-founder of SABCS, died during SABCS18.

The goal of the scholarships is to encourage and aid researchers who are early in their career, in getting their work seen and disseminated.

The #SABCS19 award recipients are:






SABCS Basic Science Scholar Award Recipients — For laboratory-based investigators-in-training whose work focuses on the biology of breast cancer and preclinical models of its development and progression.

  • Hemn Mohammadpour, PhD, Roswell Park Comprehensive Cancer Center, Buffalo, New York: B2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells P3-01-02, Thursday, Dec. 12, 5 p.m.
  • Ofir Cohen, PhD, Dana-Farber Cancer Institute, Boston: A joint atlas of single-cell and bulk RNA-seq in metastatic breast cancer allows inference of oncogenic and drug-resistant transcriptional programs in malignant cells and the tumor microenvironment GS6-05, Friday, Dec. 13, 4:15 p.m.
  • Hakwoo Lee, University of British Columbia, Vancouver, Canada: Single-cell analysis of breast cancer metastasis using patient-derived xenograft model reveals clonal relationship between primary tumor and its metastases PD8-05, Thursday, Dec. 12, 5 p.m.
  • Shir Schlosser, Tel Aviv University, Tel Aviv, Israel: Risk of radiation induced secondary malignancies in gBRCA carriers following breast cancer therapy PD6-04 Thursday, Dec. 12, 5 p.m.
  • Aatish Thennavan, University of North Carolina, Chapel Hill, North Carolina: Molecular signatures of DCIS to invasive progression for basal-like breast cancers: An integrated mouse model and human tumor study PD6-09 Thursday, Dec. 12, 5 p.m.






SABCS Clinical Scholar Award Recipients — For clinical scientists-in-training who are actively pursuing clinical or clinical/translational research in breast cancer.

  • Kristen Carroll, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago: Clinico-pathological and molecular features in young women with metastatic breast cancer PD8-03 Thursday, Dec. 12, 5 p.m.
  • Melissa Edwards, MB ChB, University of Auckland, New Zealand: The impact of breast cancer treatment concordance on survival in relation to comorbidity burden P3-08-02 Thursday, Dec. 12, 5 p.m.
  • Kush Lohani, MD, All India Institute of Medical Sciences, New Delhi: Comparison of 4 techniques of clinical breast examination: A cross-sectional diagnostic test evaluation P2-02-01 Thursday, Dec. 12, 7 a.m.
  • Veronica Mariotti, MD, Moffitt Cancer Center, Tampa, Florida: Results of a phase II double-blinded, randomized, placebo-controlled clinical trial of Indoximod, an Indoleamine-2,3-dioxygenase 1 (IDO1) inhibitor, in combination with Taxane PD1-04 Wednesday, Dec. 11, 5 p.m.
  • Natsuko Onishi, MD, PhD, University of California San Francisco: Lack of background parenchymal enhancement suppression in breast MRI during neoadjuvant chemotherapy may be associated with inferior treatment response in hormone receptor positive breast cancer PD9-05 Friday, Dec. 13, 7 a.m.






Coltman Scholar Award Recipients — In memory of Dr. Charles A. Coltman, co-founder of SABCS, to commemorate the significant contributions he made to oncology medicine. For clinical scientists-in-training.

  • Mathilde Almekinders, MD, Netherlands Cancer Institute, Amsterdam: Impact of increased mammary adiposity on DCIS progression P6-15-07 Saturday, Dec. 14, 7 a.m.
  • Alexandra Desnoyers, MD, Princess Margaret Cancer Center, Toronto: Fragility index of trials supporting approval of breast cancer drugs P4-15-01 Friday, Dec. 13, 7 a.m.
  • Joshua Drago, MD, Memorial Sloan Kettering Cancer Center, New York: Genomic profiling of primary and metastatic breast cancer in men P4-17-01 Friday, Dec. 13, 7 a.m.
  • Yash Huilgol, University of California San Francisco, San Francisco: Breast cancer risk thresholds as a predictor of chemoprevention uptake in the Athena Breast Health Network P5-08-01 Friday, Dec. 13, 5 p.m.
  • Nathalie LeVasseur, MD, BC Cancer, Vancouver, British Columbia: Impact of ER-positivity on time and pattern of relapse in early-stage breast cancer patients P3-08-04 Thursday, Dec. 12, 5 p.m.



Arti Hurria Travel Award Recipients — Created in memory of Dr. Arti Hurria and in recognition of her commitment to the mentorship and training of the next generation of geriatric oncologists. For geriatric oncologists-in-training.

  • Nicolò Matteo Luca Battisti, MD, PhD, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom: Use of systemic therapy for early stage breast cancer in older adults: results from the Bridging the Age Gap study P2-14-08 Thursday, Dec. 12, 7 a.m.
  • Demetria Smith-Graziani, MD, University of Texas MD Anderson Cancer Center, Houston: Delayed initiation of adjuvant chemotherapy in older women with breast cancer P2-14-04 Thursday, Dec. 12, 7 a.m.






AACR Associate Award Merit Recipients — For presenters of meritorious abstracts who are Associate Members of the American Association for Cancer Research (AACR).

  • Yara Abdou, MD, Roswell Park Comprehensive Cancer Center, Buffalo, New York: Racial differences in infiltration of CD8+ T-cells in breast tumors of Black and White women P2-10-02 Thursday, Dec. 12 7 a.m.
  • Kristin Altwegg, MS, University of Texas Health San Antonio: Development and characterization of a first-in-class small molecule inhibitor of PELP1 P3-10-01 Thursday, Dec. 12, 5 p.m.
  • Isaac Chan, MD, PhD, Johns Hopkins University, Baltimore: A dual role of natural killer cells in breast cancer metastasis P3-01-01 Thursday, Dec. 12, 5 p.m.
  • Chi Gao, MS, Harvard T.H. Chan School of Public Health, Boston: Polygenic risk scores provide clinically meaningful risk stratification among women carrying moderate penetrance pathogenic variants in breast cancer predisposition genes: Results from the CARRIERS study PD3-02 Wednesday, Dec. 11, 5 p.m.
  • Lorenzo Gerratana, MD, Northwestern University, Chicago: Liquid biopsy methods and machine learning modeling to understand organ tropism and metastasization behavior of metastatic breast cancer P3-01-05 Thursday, Dec. 12, 5 p.m.






  • Sofia Mastoraki, PhD, University of Texas MD Anderson Cancer Center, Houston: Assessment of intratumoral heterogeneity in early stage estrogen receptor (ER) positive breast cancer P4-06-03 Friday, Dec. 13, 7 a.m.
  • Rosalyn Sayaman, PhD, City of Hope, Duarte, California: Application of machine learning to elucidate the biology predicting response in the I-SPY 2 neoadjuvant breast cancer trial P1-21-08 Wednesday, Dec. 11, 5 p.m.
  • Alberto Servetto, MD, University of Texas Southwestern Medical Center, Dallas: Fibroblast growth factor receptor 1 associates with promoters genome-wide and regulates gene transcription in ER+/FGFR1-amplified breast cancer: Implications for endocrine resistance PD7-04 Thursday, Dec. 12, 5 p.m.
  • Vrutant Shah, PhD, University of Texas MD Anderson Cancer Center, Houston: A novel model to study to metaplastic TNBC P1-03-01 Wednesday, Dec. 10, 5 p.m.
  • Siddhartha Yadav, MD, Mayo Clinic, Rochester, Minnesota: Comparison of recommendations for germline genetic testing in an unselected cohort of patients with breast cancer P6-08-01 Saturday, Dec. 14, 7 a.m.

Visit the following link for the complete #SABCS19 schedule. Registration for the symposium is open through Nov. 22. Visit to register today.


Categories: Program | Tags: San Antonio Breast Cancer Symposium, SABCS, American Association for Cancer Research, AACR, Arti Hurria, Charles Coltman | View Count: (6034) | Return

Post a Comment